Anavex Leife Sciences +24% Premarket @$6.50; May be Attributed to Report on Australian Alzheimer's Trial
April 25, 2016 at 07:08 AM EDT
http://www.9news.com.au/national/2016/04/24/19/51/alzheimers-breakthrough-in-melbourne-drug-trial#dfSrjdAC1puZClCF.99